dilazep has been researched along with Plasmodium falciparum Malaria in 2 studies
Dilazep: Coronary vasodilator with some antiarrhythmic activity.
dilazep : A member of the class of diazepanes that is 1,4-diazepane substituted by 3-[(3,4,5-trimethoxybenzoyl)oxy]propyl groups at positions 1 and 4. It is a potent adenosine uptake inhibitor that exhibits antiplatelet, antianginal and vasodilator properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gero, AM | 2 |
| Upston, JM | 1 |
| Wood, AM | 1 |
2 other studies available for dilazep and Plasmodium falciparum Malaria
| Article | Year |
|---|---|
Altered purine nucleoside transport as a target for malaria chemotherapy.
Topics: Adenosine; Affinity Labels; Alkaloids; Animals; Antimalarials; Benzodioxoles; Benzoquinones; Biologi | 1994 |
New nucleoside transport pathways induced in the host erythrocyte membrane of malaria and Babesia infected cells.
Topics: Adenosine; Animals; Babesia bovis; Babesiosis; Biological Transport; Cattle; Cattle Diseases; Dilaze | 1991 |